<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-26T07:29:22Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/4871" metadataPrefix="mods">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/4871</identifier><datestamp>2024-09-12T11:46:36Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
   <mods:name>
      <mods:namePart>González Hedström, Daniel</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Fuente Fernández, María De La</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Priego Cuadra, Teresa</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Martín Velasco, Ana Isabel</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Amor, Sara</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>López-Calderón Barreda, Asunción</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Inarejos García, Antonio Manuel</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>García Villalón, Ángel Luís</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Granado, Miriam</mods:namePart>
   </mods:name>
   <mods:extension>
      <mods:dateAvailable encoding="iso8601">2023-06-16T14:22:42Z</mods:dateAvailable>
   </mods:extension>
   <mods:extension>
      <mods:dateAccessioned encoding="iso8601">2023-06-16T14:22:42Z</mods:dateAccessioned>
   </mods:extension>
   <mods:originInfo>
      <mods:dateIssued encoding="iso8601">2021-07-01</mods:dateIssued>
   </mods:originInfo>
   <mods:identifier type="citation">González Hedström, D., Fuente Fernández, M., Priego Cuadra, T. et al. «Addition of Olive Leaf Extract to a Mixture of Algae and Extra Virgin Olive Oils Decreases Fatty Acid Oxidation and Synergically Attenuates Age-Induced Hypertension, Sarcopenia and Insulin Resistance in Rats». Antioxidants, vol. 10, n.o 7, julio de 2021, p. 1066. DOI.org (Crossref), https://doi.org/10.3390/antiox10071066.</mods:identifier>
   <mods:identifier type="issn">2076-3921</mods:identifier>
   <mods:identifier type="doi">10.3390/antiox10071066</mods:identifier>
   <mods:identifier type="uri">https://hdl.handle.net/20.500.14352/4871</mods:identifier>
   <mods:identifier type="officialurl">https://doi.org/10.3390/antiox10071066</mods:identifier>
   <mods:identifier type="relatedurl">https://www.mdpi.com/2076-3921/10/7/1066/htm</mods:identifier>
   <mods:abstract>Olive-derived products, such as virgin olive oil (EVOO) and/or olive leaf extracts (OLE), exert anti-inflammatory, insulin-sensitizing and antihypertensive properties and may be useful for stabilizing omega 3 fatty acids (n-3 PUFA) due to their high content in antioxidant compounds. In this study, the addition of OLE 4:0.15 (w/w) to a mixture of algae oil (AO) rich in n-3 PUFA and EVOO (25:75, w/w) prevents peroxides formation after 12 months of storage at 30 °C. Furthermore, the treatment with the oil mixture (2.5 mL/Kg) and OLE (100 mg/Kg) to 24 month old Wistar rats for 21 days improved the lipid profile, increased the HOMA-IR and decreased the serum levels of miRNAs 21 and 146a. Treatment with this new nutraceutical also prevented age-induced insulin resistance in the liver, gastrocnemius and visceral adipose tissue by decreasing the mRNA levels of inflammatory and oxidative stress markers. Oil mixture + OLE also attenuated the age-induced alterations in vascular function and prevented muscle loss by decreasing the expression of sarcopenia-related markers. In conclusion, treatment with a new nutraceutical based on a mixture of EVOO, AO and OLE is a useful strategy for improving the stability of n-3 PUFA in the final product and to attenuate the cardiometabolic and muscular disorders associated with aging.</mods:abstract>
   <mods:language>
      <mods:languageTerm>eng</mods:languageTerm>
   </mods:language>
   <mods:accessCondition type="useAndReproduction">https://creativecommons.org/licenses/by/3.0/es/</mods:accessCondition>
   <mods:accessCondition type="useAndReproduction">open access</mods:accessCondition>
   <mods:accessCondition type="useAndReproduction">Atribución 3.0 España</mods:accessCondition>
   <mods:titleInfo>
      <mods:title>Addition of Olive Leaf Extract to a Mixture of Algae and Extra Virgin Olive Oils Decreases Fatty Acid Oxidation and Synergically Attenuates Age-Induced Hypertension, Sarcopenia and Insulin Resistance in Rats</mods:title>
   </mods:titleInfo>
   <mods:genre>journal article</mods:genre>
</mods:mods></metadata></record></GetRecord></OAI-PMH>